Blueprint Medicines Vs. Sarepta Therapeutics Industry Stock Comparison

Sell

31

BPMC
Blueprint Medicines

Last Price:

$87.17

Seasonality Move:

2.07%

Sell

42

SRPT
Sarepta Therapeutics

Last Price:

$121.53

Seasonality Move:

9.24%

Sell

31

Blueprint Medicines (BPMC) is a Sell

Is Blueprint Medicines a Buy, Sell or Hold?

The current Blueprint Medicines [BPMC] share price is $87.22. The Score for BPMC is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
BPMC is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

Sell

42

Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

The current Sarepta Therapeutics [SRPT] share price is $121.59. The Score for SRPT is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

BPMC Stock Price Chart

What is Blueprint Medicines's stock price today?

The Blueprint Medicines share price today is $87.22

Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BPMC is experiencing slight buying pressure.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

The Sarepta Therapeutics share price today is $121.59

Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing slight buying pressure.

BPMC Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-1.52	Sell
Relative Strength Index (14 RSI):	37.75	Sell
Chaikin Money Flow:	85830	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(90.18 - 96.26)	Sell
Bollinger Bands (100):	(87.37 - 95.71)	Sell

SRPT Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-0.38	Sell
Relative Strength Index (14 RSI):	47.98	Sell
Chaikin Money Flow:	14371	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(120.06 - 129.7)	Sell
Bollinger Bands (100):	(117.97 - 133.69)	Sell

BPMC Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	89.37	Sell
20-day SMA:	92.65	Sell
50-day SMA:	92.51	Sell
200-day SMA:	96.69	Sell
8-day EMA:	89.52	Sell
20-day EMA:	91.55	Sell
50-day EMA:	92.48	Sell
200-day EMA:	91.6	Sell

SRPT Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	121.08	Buy
20-day SMA:	123.89	Sell
50-day SMA:	122.63	Sell
200-day SMA:	129.62	Sell
8-day EMA:	121.85	Sell
20-day EMA:	122.51	Sell
50-day EMA:	123.28	Sell
200-day EMA:	125.75	Sell

Blueprint Medicines Earnings Growth & BPMC Earnings Dates

Analysts estimate an earnings increase this quarter of $0.73 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.57 per share, and an increase next year of $2.93 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

Analysts estimate an earnings increase this quarter of $2.79 per share, a decrease next quarter of $0.00 per share, an increase this year of $7.84 per share, and an increase next year of $4.82 per share.

Blueprint Medicines Technical Analysis

	Dec 17	Dec 18	Dec 19	Dec 20	Dec 23	Dec 24	Dec 26	Dec 27	Dec 30	Dec 31
	Dec
	17	18	19	20	23	24	26	27	30	31
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

	Dec 17	Dec 18	Dec 19	Dec 20	Dec 23	Dec 24	Dec 26	Dec 27	Dec 30	Dec 31
	Dec
	17	18	19	20	23	24	26	27	30	31
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):